insurance, Medicaid, drug assistance programs. I also think the over-pricing of drugs is irresponsible. We all know the cost and risk to develop a drug very well so the cost is justifiable up to a point. I am happy we are not sticking to the $120k/yr. If this gets to market at $35k/yr I think that would be good.